| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 5 | |
| #2 | Australia | 3 | |
| #3 | Canada | 3 | |
| #4 | China | 3 | |
| #5 | EPO (European Patent Office) | 3 | |
| #6 | Republic of Korea | 3 | |
| #7 | United States | 3 | |
| #8 | Singapore | 2 | |
| #9 | Taiwan | 2 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Heterocyclic compounds | |
| #2 | Medical preparations | |
| #3 | Therapeutic chemical compounds | |
| #4 | Sugars |
| # | Name | Total Patents |
|---|---|---|
| #1 | Yang Zhiqiang | 27 |
| #2 | Tan John Qiang | 26 |
| #3 | Lee Francis | 25 |
| #4 | Wu Wen-Lian | 24 |
| #5 | Wu Wen Lian | 3 |
| #6 | Lee Francis Yu-Hui | 2 |
| #7 | Tan John Q | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2020243178A1 | Heterocyclic compounds as prmt5 inhibitors | |
| CN111511361A | Aminocarbonate and urea compounds as multikinase inhibitors | |
| KR20200096265A | Heterocyclic compounds as PRMT5 inhibitors | |
| AU2018364938A1 | Macrocyclic compounds as TRK kinase inhibitors and uses thereof | |
| US2020239464A1 | Cyclic compounds as immunomodulating agents |